Zepto Life Technology’s mould infection panel obtains FDA breakthrough designation
Zepto Life Technology’s invasive mould detection test has secured a breakthrough device designation from the US Food and Drug Administration …
Zepto Life Technology’s invasive mould detection test has secured a breakthrough device designation from the US Food and Drug Administration …
SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) have signed a memorandum of understanding (MoU) that will set in …
Roche has announced the rapid development of a research-use-only (RUO) molecular polymerase chain reaction (PCR) test to detect the rare …
GE HealthCare has received 510(k) clearance from the US Food and Drug Administration (FDA) for its medical imaging management (MIM) …
CereVasc has raised $85m, providing the clinical stage company with a cash runway to support the ongoing development of its …
Noctrix Health has been acquired by ResMed in a $340m deal, representing the first portfolio company exit for Angelini Ventures, …
Medtronic has submitted several regulatory filings to the US Food and Drug Administration (FDA) as it seeks to broaden the …
Insulet has begun distributing an updated version of its Omnipod 5 automated insulin delivery (AID) system across the US, following …
Medtronic has reported total revenue of $36.4bn in fiscal year 2026 (FY26), a figure the company said reflects the highest …
New data from HeartBeam has highlighted the company’s namesake electrocardiogram’s (ECG’s) potential in identifying heart attacks in patients experiencing chest …
Stryker has launched TPX HD, a new small bone power tool aimed at supporting a range of complex orthopaedic procedures, …
Philips has received the US Food and Drug Administration (FDA) 510(k) clearance for Elevate Plus, an upgrade that adds new …
Subtle Medical has raised $33m and appointed a new CEO to advance commercialisation activities surrounding its artificial intelligence (AI)-based medical …
On 28 April 2026, the European Medicines Agency (EMA) launched a pilot pathway designed to support the development of breakthrough medical …
New prospective sub-study analysis data presented by Abbott at the 2026 American Society of Clinical Oncology (ASCO) meeting has highlighted …